Funding for this research was provided by:
the unit of research and development (FoU), Skaraborg hospital Skövde (300)
Astellas company (500)
Article History
Received: 10 October 2017
Accepted: 12 September 2018
First Online: 25 September 2018
Ethics approval and consent to participate
: Ethical approval by the regional ethical review board (EPN) in Gothenburg was given in 2010, number 658–09, for an extra screening of Mycoplasma genitalium in order to lower the amount of post abortion infections. All therapeutic abortions in Sweden are reported to the National Board of Health and Welfare. No consent was therefore needed to collect information about gestational age, the number of previous abortions, abortion method or the age of patients. At our hospital, we register all given antibiotics and the reason for treatment as a quality control and for statistical purposes. Therefore, there is no need for consent to collect data from the bacterial screening process. No consent was needed for the prospective part. Follow up appointments 1 month after the abortions were standard procedures even before we started collecting data for this study.
: Consent for publication was not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.